克唑替尼相关肝囊肿与肾囊肿:一例附MRI表现的病例报告
报道一名60多岁ROS1融合阳性肺腺癌男性,克唑替尼治疗期间出现双肾及肝脏多发囊性病变,伴发热、腹痛、少尿。增强CT示新发囊肿,部分壁厚、有分隔、内容物高密度;MRI示T2信号不均、T1混杂低至高信号,部分囊壁呈T2低信号/T1高信号,扩散受限主要位于肿块周边。囊液穿刺细胞学仅见细胞数增多(含中性粒细胞),未见恶性细胞或微生物;停用克唑替尼后症状改善、随访影像示囊肿消退。
要点
- 克唑替尼治疗期间新发双肾及肝脏多发囊肿,部分壁厚、有分隔、内容物高密度,需考虑药物相关囊肿。
- MRI上囊壁T2低信号/T1高信号及周边扩散受限提示出血成分,有助与转移瘤和脓肿鉴别。
- 囊液细胞学仅见细胞数增多(含中性粒细胞),未见恶性细胞或微生物。
核心结论
- 克唑替尼相关肝、肾囊肿具有特征性MRI表现,如囊壁T2低信号/T1高信号及扩散受限主要位于肿块周边,提示出血成分,可能有助于与其他病变(包括转移瘤和脓肿)鉴别。
研究设计与样本
- 病例报告;1例60多岁ROS1融合阳性肺腺癌男性,克唑替尼治疗期间出现双肾及肝脏多发囊性病变;行增强CT、MRI及经皮囊肿穿刺细胞学检查。
关键影像表现/征象
- 增强CT示双肾及肝脏新发囊性病变,部分囊壁增厚、有分隔、内容物呈高密度。
- MRI示T2加权成像信号不均,T1加权成像呈混杂低至高信号。
- 部分囊肿囊壁见T2低信号、T1高信号区域,扩散受限主要位于肿块周边。
临床应用与阅片要点
- 克唑替尼治疗期间新发双肾及肝脏多发囊肿,影像上需考虑药物相关囊肿。
- 囊壁T2低信号/T1高信号及周边扩散受限提示出血成分,可能有助于与转移瘤和脓肿鉴别。
- 经皮囊肿穿刺细胞学示细胞数增多(含中性粒细胞),未见恶性细胞或微生物。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
We report a case of a man in his 60s with ROS1 fusion-positive lung adenocarcinoma who developed multiple cystic lesions in both the kidneys and liver during crizotinib treatment. The patient presented with fever, abdominal pain, and oliguria. Contrast-enhanced CT revealed new cystic lesions in both the kidneys and liver, with some showing thick walls, septa, and hyperdense contents. MRI demonstrated heterogeneous signal intensities on T2-weighted images and mixed low to high signal intensities on T1-weighted images. Some cysts displayed T2 hypointense and T1 hyperintense areas along the cyst walls, with diffusion restriction predominantly at the periphery of the masses. Percutaneous drainage of the cysts was performed, and cytology revealed an increase in the number of cells, including neutrophils. However, no malignant cells or microorganisms were detected. Based on these imaging findings and laboratory results, the patient was diagnosed with crizotinib-associated renal and hepatic cysts. Symptoms improved after crizotinib discontinuation, and follow-up imaging showed cyst regression. This is the first report describing MRI findings for crizotinib-associated hepatic cysts. Characteristic MRI findings, such as T2 hypointensity/T1 hyperintensity along the cyst walls and diffusion restriction predominantly at the periphery of the masses, suggesting hemorrhagic components, may help differentiate crizotinib-associated cysts from other lesions, including metastases and abscesses.
引用
- Yamamoto S, Kawahata T, Masuoka S, et al. Crizotinib-associated hepatic and renal cysts: a case report with MRI findings. Abdom Radiol (NY). 2025. PMID: 40137948. doi:10.1007/s00261-025-04894-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。